Protara Therapeutics, Inc. — Director's Dealing 2015

Jun 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2015-06-02

Reporting Person: Toner E. Scott (Senior VP of Marketing)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-02	Stock Option (Right to Buy)	$17.59	A	50000	Acquired	2025-06-02	Common Stock, $0.001 par value (50000)	Direct

Footnotes

F1: The options were granted on June 2, 2015 and will vest over four years, with 25% vesting on the first anniversary of Mr. Toner's date of hire, June 1, 2015, and the remaining 75% vesting in twelve equal quarterly installments on the last calendar day of each three-month quarterly period following the first anniversary of his date of hire.